Sulfonylurea prescription patterns in elderly patients with type 2 diabetes mellitus: A comprehensive analysis of real‐world data from pharmacies in Japan
Analysis of real-world sulfonylurea prescription data found guideline non-adherence, namely, excessive prescription of glimepiride, use of glibenclamide in elderly patients, and common coprescription with dipeptidyl peptidase-4 inhibitors. These findings might provide an opportunity to reconsider the treatment of patients with type 2 diabetes mellitus who are over-prescribed sulfonylureas to reduce residual risks, such as hypoglycemia.
Authors
- Masaya Sakamoto (ORCID: https://orcid.org/0000-0001-7839-0780)
- Michiko Yamazaki
- Shunya Ikeda (ORCID: https://orcid.org/0000-0001-6180-246X)
- Masaya Hosokawa (ORCID: https://orcid.org/0000-0002-2336-9113)
- Tomoya Saika (ORCID: https://orcid.org/0000-0001-9690-3244)
- TOHRU TAKEBE
- Yutaka Nakao
Institutions
- Mita Hospital (JP)
- International University of Health and Welfare (JP)
Publication Details
- Journal
- Journal of Diabetes Investigation
- Published
- 2024-09-03
- DOI
- https://doi.org/10.1111/jdi.14302
- Citations
- 1
- Primary Topic
- Pharmaceutical Practices and Patient Outcomes
- Type
- article
- Field-Weighted Citation Impact
- 0.34